Maxzar-PG Tablet SR is a sustained-release formulation combining Methylcobalamin 1500 mcg and Pregabalin 75 mg, designed for the management of neuropathic pain and related neurological disorders. Methylcobalamin, an active form of Vitamin B12, plays a crucial role in nerve regeneration, myelin sheath repair, and improvement of nerve conduction, thereby aiding in the treatment of peripheral neuropathies and vitamin B12 deficiency-related neurological conditions. Pregabalin, an anticonvulsant and analgesic agent, modulates calcium channels in the central nervous system, reducing neurotransmitter release and effectively alleviating neuropathic pain, including diabetic neuropathy, postherpetic neuralgia, and fibromyalgia. The sustained-release formulation ensures prolonged therapeutic plasma concentrations, enhancing patient compliance by reducing dosing frequency and minimizing peak-trough fluctuations. Maxzar-PG is indicated for patients requiring combined neurotrophic support and neuropathic pain relief. It should be used under medical supervision, with dosage adjustments based on clinical response and tolerability. Common adverse effects may include dizziness, somnolence, and gastrointestinal disturbances. Caution is advised in patients with renal impairment, and gradual dose titration is recommended to mitigate side effects. Maxzar-PG Tablet SR offers a synergistic approach to managing neuropathic conditions by addressing both nerve repair and symptomatic pain control.